0001437749-21-009761.txt : 20210426 0001437749-21-009761.hdr.sgml : 20210426 20210426083352 ACCESSION NUMBER: 0001437749-21-009761 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20210426 DATE AS OF CHANGE: 20210426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boswell Richard CENTRAL INDEX KEY: 0001736940 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21851668 MAIL ADDRESS: STREET 1: 2408 EASTERN AVE. CITY: ROCHESTER HILLS STATE: MI ZIP: 48307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 5 1 rdgdoc.xml FORM 5 X0306 5 2017-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736940 Boswell Richard 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 1 Senior Executive VP, CFO* Common Stock 2017-11-30 4 A 0 L 4500000 0 A 4528571 D Common Stock 2017-11-30 4 A 0 L 20000 0 A 4528571 D 4,520,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to two restricted stock agreements pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. * Mr. Boswell ceased serving as the issuer's Chief Financial Officer on May 16, 2019. /s/ Richard Boswell 2021-04-26